Influvac
Lua error in package.lua at line 80: module 'strict' not found. Influvac is a sub-unit vaccine produced and marketed by Abbott Laboratories. It contains inactivated purified surface fragments (sub-units) from the three different strains of the influenza virus (A/H1N1, A/H3N2, and Influenza B Virus) that are selected and distributed by the World Health Organization, on the basis of their latest recommendations.[1]
In February 2010, Abbott acquired the vaccines sub-unit from Solvay Pharmaceuticals included in its $6.2 billion purchase[2] and the sub-unit influenza vaccine - Influvac has been commercially available on the market since the early nineteen-eighties.[1] With the acquisition of Solvay, Abbott retained access to the Eastern European, Middle Eastern & Latin American markets. Approximately $850 million of sales revenue from vaccines was reported by Solvay Pharmaceuticals in 2009.[2]
References
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This immunology article is a stub. You can help Wikipedia by expanding it. |
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This infectious disease article is a stub. You can help Wikipedia by expanding it. |
